Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Athersys Stock Quote

Athersys (NASDAQ: ATHX)

Price as of May 24, 2024, 2:13 p.m. ET

Athersys Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
ATHX -99.49% -99.99% -83.85% -100%
S&P +27.79% +87.71% +13.41% +255%

Athersys Company Info

Athersys, Inc. is a biotechnology company, which focuses on the field of regenerative medicine. It engages in the discovery and development of therapies designed to extend and enhance the quality of human life. The firm offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

News & Analysis


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.